Fadrozole [fadrozol]
topical
- Terms
-
CGS 020286A
CGS-020286A
CGS-16949A
CGS020286A
FAD 286
FAD-286
FAD286
Fadrozole Hydrochloride
Fadrozole Monohydrochloride
Persistent link
https://www.medvik.cz/link/D017316
Definition
A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.
- DUI
- D017316 MeSH Browser
- CUI
- M0026296
- CAS
- Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-
- Previous indexing
- Imidazoles (1988-1992); Nitriles (1988-1992)
- History note
- 1993
- Public note
- 1993; CGS 16949A was indexed under IMIDAZOLES & NITRILES 1988-1992; CGS 020286A was indexed under FADROZOLE 2012, and under IMIDAZOLES & IMIDAZOLES 2010-2011
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.626.310
o-Chlorobenzylidenemalonitrile
D02.626.400
Fadrozole
D03.383.129.308.090
Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide
D03.383.129.308.100
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
D03.383.129.308.270
Fadrozole
D03.383.129.308.385
Histidinol
D03.383.129.308.445
Impromidine
D03.383.129.308.626
Niridazole